Appen Ltd (ASX:APX) and this ASX growth share could be the ones to buy for strong returns in 2021 and beyond…
The post 2 of the best ASX growth shares to buy for 2021 and beyond appeared first on The Motley Fool Australia. –
Looking to add a few growth shares to your portfolio next week? Then you might want to get better acquainted with the ones listed below.
The two shares listed below have been growing strongly and have been tipped to continue doing so in the future. Here’s what you need to know about them:
Appen Ltd (ASX: APX)
The first growth share to look at is Appen. It is the global leader in the development of high-quality, human annotated datasets for machine learning and artificial intelligence. Given the explosive growth of these markets, it has been growing at a strong rate over the last few years. While the pandemic is putting a dampener on things in FY 2021, management appears confident that demand will accelerate once the crisis passes and its strong form will resume.
According to a note out of Citi from last week, its analysts have a buy rating and $32.60 price target on the company’s shares. This compares to the latest Appen share price of $24.85. They believe recent share price weakness is a buying opportunity and remain very positive on its long term growth prospects.
ResMed Inc. (ASX: RMD)
Due to the growing demand for its industry-leading products in the fast-growing sleep treatment market, ResMed is another company which has been growing strongly in recent years. In fact, this strong form even continued in FY 2020 despite the pandemic. And with trading conditions improving, FY 2021 looks set to be another positive year of growth.
One broker that is very positive on the company’s future is Credit Suisse. Last month it upgraded the company’s shares to an outperform rating with a $31.00 price target. Its analysts believe ResMed is very well placed to benefit from a shift to home healthcare following the pandemic. Overall, it believes the company is capable of delivering double digit earnings growth for a number of years. The ResMed share price last traded at $28.25.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
- How to turn $20,000 into over $250,000 in 10 years with ASX shares
- The ResMed (ASX:RMD) share price is up 25% in 2020
- ASX healthcare shares could outperform in 2021: Fundie
- Top ASX shares to buy in 2021
- Should you buy the Appen (ASX:APX) share price dip?
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Appen Ltd. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post 2 of the best ASX growth shares to buy for 2021 and beyond appeared first on The Motley Fool Australia.